Exchange: NYSE·Updated 07:58 PM EDT

TMO News

News
all
press releases
Should You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
Zacks
More News
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
PacBio cut its 2026 revenue outlook as weaker instrument demand and a slower SPRQ-Nx transition raised the stakes for clinical adoption.
Zacks
TMO Stock Could Gain Following the Launch of EMPAD G2 Detector
Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.
Zacks
Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET).You can access the live...
Business Wire
Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.87% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientific has a marketread more...
Benzinga
Delta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC's 'Final Trades'
Experts recommend Delta, Thermo Fisher, Target, and Interactive Brokers Group, Inc. due to strong earnings and guidance.read more...
Benzinga
Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.
Zacks
The Zacks Analyst Blog Highlights Amgen, Thermo Fisher Scientific, PepsiCo, C&F Financial and Acorn Energy
Amgen, Thermo Fisher and PepsiCo headline Zacks??? latest research, with growth drivers, raised outlooks and key risks in focus.
Zacks
Top Research Reports for Amgen, Thermo Fisher & Pepsi
Amgen, Thermo Fisher and PepsiCo headline today's research, with growth drivers, strategic moves and key risks in focus.
Zacks

Advertisement|Remove ads.